Target-based Repurposing

Target-Based Repurposing is a drug repurposing strategy that identifies new therapeutic indications for existing drugs by systematically exploiting their known or predicted interactions with specific molecular targets or biomarkers, typically via experimental or computational screening against disease-relevant proteins or pathways.

65

Publications

4.6K

Citations

428

Authors

166

Institutions

Publications per year

2017–2026

47

Authors

428

  1. RK
    Ryan Kelley

    University of California San Diego, United States

    2 publications · 1.1K citations

    2

    h-index

  2. AF
    Arnica F Lal

    Sam Higginbottom Institute of Agriculture, India

    2 publications · 23 citations

    2

    h-index

  3. LG
    Luana Galver

    Illumina (United States), United States

    2 publications · 1.1K citations

    2

    h-index

  4. JP
    Juan P. Casas

    University College London, United Kingdom

    2 publications · 1.1K citations

    2

    h-index

  5. JE
    Jorgen Engmann

    University College London, United Kingdom

    2 publications · 1.1K citations

    2

    h-index

1–5 of 428

Venues

  1. Life Sciences

    4 publications · 966 citations

    4

    h-index

  2. Nature Communications

    3 publications · 167 citations

    3

    h-index

  3. Nature

    3 publications · 161 citations

    3

    h-index

  4. ChemRxiv

    Repository · 2 publications · 23 citations

    2

    h-index

  5. Briefings in Bioinformatics

    2 publications · 72 citations

    2

    h-index

1–5